Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Dates
Amedisys, a leader in home health and hospice services, will announce its financial results for the fourth quarter and full year ending December 31, 2022, on February 15, 2023. The investor conference call is scheduled for February 16, 2023, at 11:00 a.m. ET. Callers can join via toll-free (877) 524-8416 or (412) 902-1028. A replay will be available until March 16, 2023. Amedisys provides personalized care through a network of over 532 care centers, catering to more than 465,000 patients annually. Founded in 1982, the company employs roughly 20,000 staff nationwide.
- Scheduled earnings call may indicate transparency to investors.
- Significant patient reach with over 465,000 patients served annually.
- Investors await Q4 results, which may reveal financial weaknesses.
BATON ROUGE, La., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the fourth quarter and year ended December 31, 2022, after the market closes on February 15, 2023. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on February 16, 2023.
To participate on the conference call, please call a few minutes before 11:00 a.m. ET to either (877) 524-8416 (toll-free) or (412) 902-1028 (toll). A replay of the call will be available through March 16, 2023, by dialing (877) 660-6853 (toll-free) or (201) 612-7415 (toll) and entering access ID 13735891.
A live webcast of the call will be accessible through the Company website on the Investor Relations section at http://investors.amedisys.com.
About Amedisys:
Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice, personal care and high-acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; inpatient hospital, palliative, and skilled nursing facility (“SNF”) care in their homes; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 3,000 hospitals and 102,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 20,000 employees, in 532 care centers in 37 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 465,000 patients in need every year, performing more than 11.2 million visits annually. For more information about the Company, please visit: www.amedisys.com.
Contact:
| Nick Muscato | Kendra Kimmons | |
| Amedisys, Inc. | Amedisys, Inc. | |
| Investor Relations | Media Relations | |
| 615.928.5452 | 225.299.3720 | |
| nick.muscato@amedisys.com | Kendra.kimmons@amedisys.com |
FAQ
When will Amedisys report its Q4 2022 earnings?
What time is the Amedisys earnings call?
How can I participate in the Amedisys Q4 earnings call?
What is Amedisys's focus in healthcare?
